Natasha Leskovsek


I’ve taken my clinical and consulting experience for pharma and biotech companies on regulatory issues and brought them to Cooley’s clients.

+1 202 728 7131

Natasha Leskovsek advises pharmaceutical, biotechnology, medical device and food/dietary supplement industry clients on US Food and Drug Administration regulatory and clinical development matters. She also conducts regulatory diligence on behalf of entities investing in FDA-regulated companies.

Download full bio


  • Avidity Biosciences – $100 Million Series C 

  • Innate Pharma - $79 Million IPO 

  • Vir Biotechnology - $143 Million IPO 

  • Bavarian Nordic Acquires Two Commercial Vaccines from GlaxoSmithKline for €796 Million 

  • Crown Bioscience Enters Merger Agreement With JSR Corporation 

  • View all


    Providing practical compliance solutions at the intersection of science and regulation


  • Georgetown University Law Center
    JD, 1996

  • University of Maryland, College Park
    MBA, 1991

  • University of Maryland, College Park
    MPM, 1991

  • University of Maryland, Baltimore
    BSN, 1989

Admissions & Credentials

District of Columbia



  • American Health Lawyers Association

  • Food and Drug Law Institute


+1 202 728 7131 office
+1 202 842 7899 fax

1299 Pennsylvania Avenue, NW
Suite 700
Washington, DC 20004-2400